Friday, June 26, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 856 of 1,261

  1. US 8513390

    Modified antibody compositions, methods of making and using thereof

    CytomX Therapeutics, Inc. · Granted Aug 20, 2013 · Expires Aug 15, 2033

    granted

  2. US 8512751

    Pharmaceutical compositions for sleep disorders

    Collegium Pharmaceutical, Inc. · Granted Aug 20, 2013 · Expires Aug 15, 2033

    granted

  3. US 8512964

    Targets for treatment of hypercholesterolemia

    The Regents of the University of California · Granted Aug 20, 2013 · Expires Aug 15, 2033

    granted

  4. US 8513198

    Pharmaceutical formulation for reducing pain

    Jazz Pharmaceuticals International III Limited · Granted Aug 20, 2013 · Expires Aug 15, 2033

    granted

  5. US 8513282

    Modulators of cystic fibrosis transmembrane conductance regulator

    Vertex Pharmaceuticals Incorporated · Granted Aug 20, 2013 · Expires Aug 15, 2033

    granted

  6. US 8513209

    Micro-RNAS of the MIR-15 family modulate cardiomyocyte survival and cardiac repair

    The Board of Regents of the University of Texas System · Granted Aug 20, 2013 · Expires Aug 15, 2033

    granted

  7. US 8513005

    DNA immunogenic composition comprising a full-length modified poxvirus L1R gene fused to a tPA leader sequence

    The United States of America as represented by the Secretary of the Army · Granted Aug 20, 2013 · Expires Aug 15, 2033

    granted

  8. US 8512258

    Breath test device and method

    EXALENZ BIOSCIENCE LTD. · Granted Aug 20, 2013 · Expires Aug 15, 2033

    granted

  9. US 8512693

    Self-assembling membranes and related methods thereof

    Northwestern University · Granted Aug 20, 2013 · Expires Aug 15, 2033

    granted

  10. US 8512712

    Reovirus clearance of ras-mediated neoplastic cells from mixed cellular compositions

    ONCOLYTICS BIOTECH INC. · Granted Aug 20, 2013 · Expires Aug 15, 2033

    granted

  11. US 8512746

    Extended release pharmaceutical compositions of levetiracetam

    SANOVEL ILAC SANAYI VE TICARET ANONIM SIRKETI · Granted Aug 20, 2013 · Expires Aug 15, 2033

    granted

  12. US 8512755

    Compact multifunctional ligand to enhance colloidal stability of nanoparticles

    United States of America as represented by the Secretary of the Air Force · Granted Aug 20, 2013 · Expires Aug 15, 2033

    granted

  13. US 8512991

    Beta 1,4-galactosyltransferases with altered donor and acceptor specificities, compositions and methods of use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Aug 20, 2013 · Expires Aug 15, 2033

    granted

  14. US 8513197

    Ganglioside epitopes for treating Guillain-Barre syndrome

    Georgia Regents University · Granted Aug 20, 2013 · Expires Aug 15, 2033

    granted

  15. US 8513214

    C4′-substituted-2-deoxyadenosine analogs and methods of treating HIV

    The United States of America as represented by the Secretary of the Dept. of Health & Human Services · Granted Aug 20, 2013 · Expires Aug 15, 2033

    granted

  16. US 8513230

    Nuclear transport modulators and uses thereof

    Karyopharm Therapeutics Inc. · Granted Aug 20, 2013 · Expires Aug 15, 2033

    granted

  17. US 8513244

    Neprilysin inhibitors

    Theravance, Inc. · Granted Aug 20, 2013 · Expires Aug 15, 2033

    granted

  18. US 8513252

    Pyrazole derivatives and their use as positive allosteric modulators of metabotropic glutamate receptors

    Addex Pharma, S.A. · Granted Aug 20, 2013 · Expires Aug 15, 2033

    granted

  19. US 8513432

    Dual-acting benzoimidazole antihypertensive agents

    Theravance, Inc. · Granted Aug 20, 2013 · Expires Aug 15, 2033

    granted

  20. CA 2864029

    NOUVELLES UTILISATIONS PEDIATRIQUES DU CABAZITAXEL

    AVENTIS PHARMA SA [FR] · Granted Aug 15, 2013 · Expires Aug 10, 2033

    granted

  21. AU 2012210491

    IL17 and IFN-gamma inhibition for the treatment of autoimmune inflammation

    4SC DISCOVERY GMBH [DE] · Granted Aug 15, 2013 · Expires Aug 10, 2033

    granted

  22. AU 2012210489

    IL17 and IFN-gamma inhibition for the treatment of autoimmune inflammation

    4SC DISCOVERY GMBH [DE] · Granted Aug 15, 2013 · Expires Aug 10, 2033

    granted

  23. US 2013210912

    Ophthalmic Pharmaceutical Compositions and Methods of Making and Using Same

    BAUSCH & LOMB [US] · Granted Aug 15, 2013 · Expires Aug 10, 2033

    granted

  24. US 2013209398

    CONDITIONED CELL CULTURE MEDIUM COMPOSITIONS AND METHODS OF USE

    ALLERGAN INC [US] · Granted Aug 15, 2013 · Expires Aug 10, 2033

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.